APR 28, 2017 06:00 AM PDT

Disseminated Intravascular Coagulation (DIC) and Thrombosis: The Critical Role of the Lab

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Scientific Business Development Manager, Diagnostica Stago, Inc.
    Biography
      Paul earned a PhD in biochemistry from Temple University in 2006, with the subject of the dissertation regarding the function of coagulation factor XI. He also did postdoctoral training in a related area before becoming a product manager and scientific affairs specialist in 2009. During his time at Stago, Paul also completed an MBA degree program at Cornell University in 2014. He has spoken to dozens of medical technologist, clinical laboratory scientist, pharmacist and clinician audiences about various topics within hemostasis and coagulation. He also has a great interest in working with clinical pathologists, pharmacists, basic scientists, and pharmaceutical researchers to perform studies and publish, contributing to advancement of the hemostasis and coagulation science.

    Abstract:

    Disseminated Intravascular Coagulation (DIC) is a serious hypercoagulable disorder which can occur in hospitalized patients resulting in a high degree of morbidity and mortality.  DIC is a confusing disorder from both diagnostic and therapeutic standpoints resulting from several unrelated diseases which can trigger DIC, along with a lack of uniformity in clinical manifestation, laboratory diagnostic practices, and consensus on patient management.  The laboratory, by implementing the correct panel of testing methodologies, can greatly assist clinicians in patient management.  This lecture will describe the laboratory testing in order to illuminate this condition for people unfamiliar with the condition.

    Learning objectives:

    1. Describe the basic pathophysiology of DIC
    2. Demonstrate a diagnostic and management approach for DIC
    3. Compare markers of thrombin & plasmin generation in DIC, including D-Dimer, Fibrin Monomers/soluble fibrin, and fibrin degradation products (FDPs)
    4. Correlate DIC theory and testing to specific clinical case

     


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    Loading Comments...
    Show Resources